Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

CureVac taps Swiss contract drugmaker Celonic for COVID-19 vaccine production

Germany-based CureVac NV said on Tuesday it had partnered with Swiss contract manufacturer Celonic Group to produce more than 100 million doses of its COVID-19 vaccine candidate.

The vaccine, CVnCoV, will be produced at Celonic's facility in Heidelberg, Germany.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.